Company Search:
Advanced Search
Sponsored Links
Five Prime Therapeutics Inc Company Snapshot
Five Prime Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Five Prime Therapeutics Inc with three other companies in this sector in the United States: Gevo, Inc. (2016 sales of $27.21 million of which 91% was Gevo Development/Agri-Energy), Eleven Biotherapeutics Inc ($29.98 million of which 100% was Protein Therapeutic), and Blueprint Medicines Corp ($27.77 million of which 100% was Biopharmaceutical).

Sales Analysis. Sales fell dramatically in 2016: Five Prime Therapeutics Inc reported sales of $30.69 million for the year ending December of 2016. This represents a sharp decrease of 91.9% versus 2015, when the company's sales were $379.80 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Five Prime Therapeutics Inc
  Stock Performance Chart for Five Prime Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 21.19
(Figures in U.S. Dollars)
1 Week -3.0%   13 Weeks 5.7%  
4 Weeks -51.2%   52 Weeks -56.4%  
Five Prime Therapeutics Inc Key Data:
  Ticker: FPRX Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 30,691,000
(Year Ending Jan 2017).
Employees: 195
  Currency: U.S. Dollars Market Cap: 613,031,807
  Fiscal Yr Ends: December Shares Outstanding: 28,930,241
  Share Type: Common Closely Held Shares: 1,149,893
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.